AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,698 | +1.8% | 4,560 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $312,950 | +12.4% | 4,355 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $278,362 | -8.8% | 4,513 | +14.1% | 0.00% | -33.3% |
| Q4 2022 | $305,203 | -18.2% | 3,957 | -59.3% | 0.00% | 0.0% |
| Q2 2022 | $373,000 | +64.3% | 9,734 | +77.3% | 0.00% | +200.0% |
| Q1 2022 | $227,000 | -63.2% | 5,491 | -66.4% | 0.00% | -66.7% |
| Q4 2021 | $617,000 | +7.5% | 16,342 | -6.2% | 0.00% | -25.0% |
| Q3 2021 | $574,000 | +137.2% | 17,418 | +384.8% | 0.00% | +100.0% |
| Q2 2021 | $242,000 | -25.5% | 3,593 | -9.8% | 0.00% | -33.3% |
| Q4 2020 | $325,000 | +12.1% | 3,984 | -2.1% | 0.00% | -25.0% |
| Q3 2020 | $290,000 | -14.7% | 4,069 | -1.6% | 0.00% | -20.0% |
| Q2 2020 | $340,000 | -27.7% | 4,135 | -9.0% | 0.01% | -28.6% |
| Q4 2019 | $470,000 | +80.8% | 4,545 | -64.6% | 0.01% | +75.0% |
| Q3 2019 | $260,000 | – | 12,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |